Chemours Co (CC) : Private Management Group Inc reduced its stake in Chemours Co by 5.66% during the most recent quarter end. The investment management company now holds a total of 3,193,770 shares of Chemours Co which is valued at $36,568,667 after selling 191,622 shares in Chemours Co , the firm said in a disclosure report filed with the SEC on Aug 11, 2016.Chemours Co makes up approximately 2.34% of Private Management Group Inc’s portfolio.
Other Hedge Funds, Including , Tiaa Cref Investment Management boosted its stake in CC in the latest quarter, The investment management firm added 275,066 additional shares and now holds a total of 574,383 shares of Chemours Co which is valued at $6,576,685.Cambridge Investment Research Advisors reduced its stake in CC by selling 935 shares or 4.03% in the most recent quarter. The Hedge Fund company now holds 22,256 shares of CC which is valued at $202,530.Anchor Capital Advisors reduced its stake in CC by selling 83,185 shares or 31.02% in the most recent quarter. The Hedge Fund company now holds 184,956 shares of CC which is valued at $1,651,657. Chemours Co makes up approx 0.04% of Anchor Capital Advisors’s portfolio.Nisa Investment Advisors reduced its stake in CC by selling 880 shares or 24.86% in the most recent quarter. The Hedge Fund company now holds 2,660 shares of CC which is valued at $24,871.
Chemours Co opened for trading at $12.48 and hit $12.77 on the upside on Tuesday, eventually ending the session at $12.51, with a gain of 0.48% or 0.06 points. The heightened volatility saw the trading volume jump to 26,55,062 shares. Company has a market cap of $2,271 M.
On the company’s financial health, Chemours Co reported $0.27 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Aug 8, 2016. Analyst had a consensus of $0.17. The company had revenue of $1383.00 million for the quarter, compared to analysts expectations of $1418.96 million. The company’s revenue was down -8.3 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $-0.10 EPS.
The Chemours Company (Chemours) is a provider of performance chemicals. The Company delivers solutions with a range of industrial and specialty chemical products for markets including plastics and coatings refrigeration and air conditioning general industrial and mining and oil refining. The Company operates through three segments: Titanium Technologies Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2) under the brands including Ti-Pure and Vantage. Its Fluoroproducts segment is a provider of fluoroproducts under the brands including Suva ISCEON Freon Opteon Teflon Tefzel Viton Krytox Formacel Dymel FM 200 Nafion and Capstone. Its Chemical Solutions segment is a provider of industrial and specialty performance chemicals under the brands including Virkon and Oxone. The Company’s products include titanium dioxide refrigerants industrial fluoropolymer resins sodium cyanide sulfuric acid and aniline.